Dean J. Mitchell - Insider Trading & Ownership

Entity
Individual
Location
C/O Bristol Myers Squibb Co, 345 Park Ave, New York, NY
Summary
The estimated net worth of Dean J. Mitchell is at least $1.54M dollars as of June 6, 2024. Dean J. Mitchell is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $845K. Dean J. Mitchell is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $696K.
All Insider Reports
All Insider Reports

Ownership of Dean J. Mitchell

Insider Transactions Reported by Dean J. Mitchell:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.